Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Launched by LABORATOIRES THEA · Mar 29, 2012

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed and dated informed consent
• • Male or female aged from ≥ 18 years old.
• • Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study selection.
• Exclusion Criteria:
• • Best far corrected visual acuity \< 1/10
• • Severe blepharitis
• • Severe Dry Eye
• • Eyelid malposition
• • Known hypersensitivity to one of the components of the study medications or test products.
• • Pregnant or breast-feeding woman.
• • Woman of childbearing age (neither menopausal, nor hysterectomised, nor sterilized) not using effective contraception (oral contraceptives, intra-uterine device, contraceptive implant or condoms).
• • Inability of patient to understand the study procedures and thus inability to give informed consent.
• • Non compliant patient (e.g. not willing to attend the follow-up visits, way of life interfering with compliance).
• • Already included once in this study.
• • Patient under guardianship.